Avulux Lenses Enable Positive Patient Outcomes

The only clinically proven and FDA Authorized lenses that decrease the impact of migraine light sensitivity.

FDA Authorized Light sensitivity in diagnosed episodic migraine, ages 12+ Used alongside usual care, including medication — not as a replacement. Full Indications
Get Started with Avulux

Helping people living with migraine live better lives begins with Avulux.

Offer the World's Only Clinically Proven Light Management Lens

Migraine is a neurological disorder affecting the lives of more than one billion people worldwide. More than 90% of people living with migraine experience light sensitivity – the #1 most bothersome migraine symptom.

Equip patients with patented, safe, effective, and clinically proven Avulux therapeutic lenses.

Get Started with Avulux

Avulux Healthcare Provider Benefits

FDA Authorized – Prescribe with Confidence

Avulux is the only clinically proven lens for people living with migraine and light sensitivity.

Concierge Practice Support

Avulux Healthcare Providers have direct access to our team of experts including doctors and lens technologists.

100% Patient Satisfaction Guarantee

Avulux glasses are backed by a money-back guarantee, giving you the confidence to prescribe Avulux at no risk to your patients.

Low Barrier to Entry

Start recommending Avulux by registering to receive educational materials and in-practice samples.

Questions? Our team is here to help.

Our ECP support team is available from: 9am-5:30pm.
Contact Us

White Glove Onboarding

Dedicated Avulux representatives are available to enable you and your team

Trusted by Over 1,400 ECPs

There are over 1,400 Avulux Authorized Providers globally

Ongoing Support & Resources

Avulux providers have access to our team and a suite of tools to help you better serve your patients

Over 50,000

Over 50,000 Avulux wearers are managing the impact of light on their lives.

Become an
Avulux Provider

Become an Avulux Provider

Indications for Use: Avulux® is an FDA-authorized, over-the-counter precision optical filter indicated to block light at 480 nm (high blue range) and 590 nm (red/amber range), while allowing light in the remaining visible color spectrum through, to decrease the impact of light sensitivity in patients diagnosed with episodic migraine aged 12 years and older. The use of Avulux should not alter the usual care therapy of patients diagnosed with episodic migraine, including medication usage.

Avulux is intended to be used as an adjunct to other therapies for migraine-associated light sensitivity. It is not intended to diagnose, treat, cure, or prevent migraine or any other disease and is not a substitute for professional medical advice, diagnosis, or treatment. Consult a qualified healthcare professional regarding migraine symptoms and treatment. Avulux is classified by the U.S. Food and Drug Administration as a Class I medical device under 21 CFR § 882.5811, product code QEO. De Novo request DEN250026.